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http://dx
2706Objective: Increasing evidence from observational cohort studies supports a survival advantage from bilateral
internal thoracic artery (BITA) relative to single internal thoracic artery (SITA) grafts in patients undergoing
coronary artery bypass grafting. Whether the survival benefit from BITA is related to patient age and any
potential age cutoff for the loss of survival benefit from BITA remain to be determined.
Methods: Flexible parametric spline survival model was used to investigate the survival benefit from BITA
across patient age groups. The study population consisted of 4190 patients undergoing coronary artery bypass
grafting with SITA (n ¼ 3442; 81%) or BITA (n ¼ 748; 19%).
Results:A total of 376 deaths (BITA, n¼ 29; SITA, n¼ 347) were recorded after a mean follow-up of 4.9 3.2
years (maximum, 12.2 years). Nonparametric survival probabilities at 1-, 5-, and 10-year follow-ups were
94.9%  0.3% versus 98.0%  0.5%, 90.7%  0.5% versus 95.5%  0.9%, and 84.2%  1.0% versus
93.7%  1.4% in the SITA and BITA groups, respectively. Interaction between age and BITA (age*BITA)
was found to affect survival significantly (coefficient, 0.056; SE, 0.02; P ¼ .015). BITA was associated with
reduced risk of mortality in patients aged 69 years and younger (fully adjusted hazard ratio, 0.49; 95%
confidence interval, 0.24-0.98; P ¼ .04). On the other hand, for patients aged older than 69 years, BITA did
not add any significant survival advantage (adjusted hazard ratio, 1.27; 95% confidence interval, 0.75-2.14;
P ¼ .37).
Conclusions: This study provides robust scientific evidence for the loss of survival benefit from BITA for
patients older than 69 years. (J Thorac Cardiovasc Surg 2014;148:2706-11)The use of single left internal thoracic artery (SITA) to the
left anterior descending artery and saphenous vein grafts
(SVGs) for non–left anterior descending artery targets is
the standard approach in coronary artery bypass grafting
(CABG).1 This conduit selection has been consistently
shown to provide increased survival benefit and freedom
from myocardial infarction, symptoms of ischemic heart
disease, and reinterventions relative to CABG with SVGs
only.1
Although increasing evidence from observational cohort
studies supports a survival advantage from bilateral internal
thoracic artery (BITA) relative to SITA,2 there still remains
doubt as to whether BITA is the better choice for patients in
the long term as the only randomized controlled trial to date
evaluating long-term survival (the Arterial Revascularisa-
tion Trial) is still ongoing.3 Despite the increasing age ofe Department of Cardiac Surgery, Harefield Hospital, London, United
om.
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The Journal of Thoracic and Cardiovascular Surpatients undergoing CABG these days, BITA is preferen-
tially used for younger patients only. This is because the
common perception of a survival benefit is limited to
subjects with long life expectancy.4 This aspect may
partially account for the observed underuse of BITA grafts.5
Whether the survival benefit from BITA is related to the
patient’s age remains to be determined, however, as does
any potential age cutoff for the loss of survival benefit
from BITA.6-8 This information is expected to provide
evidence for the decision-making process in selecting
patients for BITA.
We aimed to investigate the potential benefit from BITA
relative to the conventional strategy with SITA and SVGs in
terms of long-term survival across patient age groups.MATERIALS AND METHODS
Study Population
The study was conducted in accordance with the principles of the
Declaration of Helsinki. The local ethical committee approved the study,
and the requirement for individual patient consent was waived. We
retrospectively analyzed prospectively collected data from the institutional
surgical database (PATS; Dendrite Clinical Systems, Ltd, Oxford, UK)
from April 2001 to May 2013. The PATS database captures detailed
information on a wide range of preoperative, intraoperative, and hospital
postoperative variables (including complications and mortality) for all
patients undergoing CABG in our institution. The data are collected and
reported in accordance with the Society for Cardiothoracic Surgery in
Great Britain & Ireland database criteria. The database is maintained bygery c December 2014
Abbreviations and Acronyms
AIC ¼ Akaike information criterion
BITA ¼ bilateral internal thoracic artery
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
SITA ¼ single internal thoracic artery
SVG ¼ saphenous vein graft
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continuous prospective data collection as part of a continuous audit
process. Data collection is validated regularly.
Cases included in the final analysis met the following criteria:
(1) first-time isolated CABG; (2) multivessel disease (3) at least 2 grafts
received; (4) surgical strategies included single left internal thoracic artery
to the left anterior descending artery and additional SVG (SITA group) or
BITAwith or without additional SVG (BITA group). Conduit selection was
based on the surgeon’s preference. Patients receiving the radial artery or the
right gastroepiploic artery were not included in this analysis.
Pretreatment Variables and Study End Point
The effect of BITA was adjusted for the following 19 pretreatment
variables: age, female sex, previous New York Heart Association
functional class III or IV, previous myocardial infarction, previous
percutaneous coronary intervention, diabetes mellitus, current smoking,
chronic obstructive pulmonary disease, cerebrovascular accident, periph-
eral vascular disease, history of atrial fibrillation, left main disease, number
of vessels diseased, left ventricular ejection fraction less than 50%, serum
creatinine level greater than 200 mmol/L, body mass index, urgent or
emergency indication, surgery performed by resident, and the use of
cardiopulmonary bypass.
The primary end point was all-cause mortality. All-cause mortality is
the most robust and unbiased index, because no adjudication is required,
thus avoiding inaccurate or biased documentation and clinical
assessments.9 Information about death from any cause is regularly obtained
from the General Register Office approximately 1 week after the event. The
General Register Office is the section of Her Majesty’s Passport Office
responsible for recording deaths in the United Kingdom, or outside the
United Kingdom if the death involves a UK citizen.
Statistical Analysis
For baseline characteristics, variables are summarized as means for
continuous variables and proportions for categoric variables.
Multiple imputation with a bootstrapping-based expectation-
maximization algorithm was used to address missing data. The fraction
of missing ranged from 0% (age) to 0.8% (body mass index). Patterns
of missingness in the data were 45, and rows after listwise deletion were
3695. The imputation model showed normal expectation-maximization
convergence. The Amelia R statistical software10 package was used for
this analysis.
To account for multiphase hazard function, BITA effect on survival was
assessed with flexible parametric modelling of time-to-event data testing
the following models: Weibull, log-logistic and the spline model of
Royston and Parmar.11 The flexsurv R package (Jackson C. 2014 Jan 20.
flexsurv: Flexible parametric survival models; http://CRAN.R-project.
org/package¼flexsurv) was used. The fitted model was selected according
to the Akaike information criterion (AIC),12 and the agreement between
fitted parametric model and nonparametric survival estimates was visually
checked. Check for age linearity was assessed with the likelihood ratio test
including age as a linear term or spline fit (quadratic). To investigate the
potential interaction effect between a patient’s age and BITA grafting onThe Journal of Thoracic and Carsurvival advantage, a second-order interaction between the treatment
indicator (BITA) and patient’s age was forced into the final survival model.
To identify the potential age cutoff for the loss of survival benefit from
BITA grafting, the adjusted hazard ratio for BITA relative to SITA, with
its 95% confidence interval (CI), was calculated across patient age and
plotted with the cubic spline method.
The R software package (R Core Team. 2012. R: A language and
environment for statistical computing. version 2.15.2; http://www.
R-project.org) was used for the various statistical analyses.
RESULTS
The study population consisted of 4190 patients
undergoing CABG with SITA (n ¼ 3442; 81%) or BITA
(n ¼ 748; 19%). Table 1 shows the pretreatment covariate
distribution between the 2 groups. The 2 groups differed
significantly in 14 of 19 pretreatment variables. Overall,
patients undergoing SITA presented a higher risk profile,
including the proportion of patients older than 70 years.
Thirty-Day Mortality
A total of 90 of the 4190 patients (2.1%) died within 30
days, with 5 of 748 (0.6%) and 85 of 3442 (2.4%) deaths
recorded in the BITA and SITA groups, respectively
(unadjusted P ¼ .004). Crude mortalities in age groups
for BITA and SITA, respectively, were 2 of 360 (0.5%)
versus 4 of 680 (0.5%) among patients younger than 60
years, 3 of 267 (1.1%) versus 22 of 1098 (2.0%) among
patients aged between 60 and 69 years, 0 of 108 (0%)
versus 42 of 1378 (3.0%) among patients aged between
70 and 79 years, and 0 of 13 (0%) versus 17 of 286
(5.9%) among patients aged 80 years or older.
Survival Analysis
A total of 376 deaths (BITA, n¼ 29; SITA, n¼ 347) were
recorded after a mean follow-up of 4.9  3.2 years
(maximum of 12.2 years). Nonparametric overall survival
probabilities at 1-, 5- and 10-year follow-up were
95.5%  0.3%, 91.5%  0.4%, and 85.8%  0.8%.
Nonparametric survival probabilities at 1-, 5-, and 10-year
follow-up were 94.9%  0.3% versus 98.0%  0.5%,
90.7%  0.5% versus 95.5%  0.9% and 84.2% 
1.0% versus 93.7% 1.4% in the SITA and BITA groups,
respectively. The flexible spline model showed the best fit
(AIC of 3320) when compared with the Weibull model
(AIC of 3362) and the log logistic model (AIC of 3365).
Excellent agreement was seen between nonparametric and
flexible parametric spline survival curves (Figure 1). The
likelihood ratio test suggested that a linear term for age
was adequate, and the quadratic term did not yield a better
fit (linear c2¼ 131; quadratic c2¼ 133; analysis of variance
P¼ .63). Table 2 shows association between covariates and
survival with univariate and multivariate flexible spline
models. Interaction between age and BITA (age*BITA)
was found to significantly affect survival (coefficient,
0.056; SE, .02; P ¼ .015). The survival benefit fromdiovascular Surgery c Volume 148, Number 6 2707
TABLE 1. Pretreatment variables in patients receiving bilateral
internal thoracic arteries or single internal thoracic artery
BITA
(N ¼ 748)
SITA
(N ¼ 3442)
P
value
Age (y, mean  SD) 60  10 68  9 <.001
Age group
<60 y 360 (48%) 680 (20%)
60-70 y 267 (36%) 1098 (32%)
70-75 y 64 (9%) 786 (23%)
5-80 y 44 (5%) 592 (17%)
>80 y 13 (2%) 286 (8%)
Female (no.) 82 (11%) 726 (21%) <.001
NYHA III/IV (no.) 149 (20%) 1067 (31%) <.001
MI (no.) 299 (40%) 1445 (42%) .45
PCI (no.) 134 (18%) 481 (14%) .004
DM (no.) 119 (16%) 1101 (32%) <.001
Active smoking (no.) 89 (12%) 344 (10%) .09
COPD (no.) 59 (8%) 378 (11%) .02
CVA (no.) 22 (3%) 240 (7%) <.001
PVD (no.) 44 (6%) 309 (9%) .008
AF (no.) 14 (2%) 103 (3%) .085
NVD (mean  SD) 2.69  0.5 2.73  0.4 .04
LAD þ diagonal (no.) 15 (2%) 76 (2%)
LAD þ Cx or RCA (no.) 203 (27%) 770 (22%)
LAD þ Cx þ RCA (no.) 530 (71%) 2596 (76%)
LMD (no.) 246 (33%) 998 (29%) .08
LVEF<50% (no.) 97 (13%) 757 (22%) <.001
Urgent or emergency indication (no.) 216 (29%) 1135 (33%) .01
Performed by resident (no.) 216 (29%) 1307 (38%) <.001
CPB (no.) 216 (29%) 1204 (35%) <.001
BMI (kg/m2) 27.51 28.01 .005
Creatinine 200 mmol/L (no.) 14 (2%) 103 (3%) .051
IABP (no.) 14 (2%) 137 (4%) .04
BITA, Bilateral internal thoracic arteries; SITA, single internal thoracic artery;
NYHA, New York Heart Association functional class; MI, myocardial infarction;
PCI, percutaneous coronary intervention; DM, diabetes mellitus; COPD, chronic
obstructive pulmonary disease; CVA, cerebrovascular accident; PVD, peripheral
vascular disease; AF, atrial fibrillation; NVD, number of vessels diseased; LAD, left
anterior descending coronary artery; Cx, circumflex coronary artery; RCA, right
coronary artery; LMD, left main disease; LVEF, left ventricular ejection fraction;
CPB, cardiopulmonary bypass; BMI, body mass index; IABP, intra-aortic balloon
pump; SD, standard deviation.
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as shown by spline analysis (Figure 2); in fact, it was
maximal for patients aged 61 years or younger (upper limit
of 95% CI<1). The survival advantage conferred by BITA
use gradually declined with increasing patient age, and it
was no longer present beyond 69 years of age.
An age of 69 years was then considered as the cutoff
point, and it provided good discrimination for the
age-related loss of survival benefit from the BITA. BITA
was associated with reduced risk of mortality for patients
aged 69 years and younger, with 15 deaths among 627
subjects receiving BITA versus 118 deaths among 1778
subjects receiving SITA (fully adjusted hazard ratio, 0.49;
95% CI, 0.24-0.98; P ¼ .04). The instantaneous risk of
death was lower in the BITA group during both early and2708 The Journal of Thoracic and Cardiovascular Surlate phases (Figure 3). On the other hand, for patients older
than 69 years, BITA did not add any significant survival
advantage, with 14 (13.6%) deaths among 121 subjects
receiving BITA (3.16% per year) versus 102 deaths
(14.5%) among 1652 subjects receiving SITA (3.02% per
year; adjusted hazard ratio, 1.27; 95% CI, 0.75-2.14;
P ¼ .37).
DISCUSSION
This study shows that BITA provided a survival benefit
related to patient age at the time of CABG. This benefit
progressively declined with age, although it remained
clinically significant until the age of 69 years.
Improvement of survival is largely considered the most
important scope of coronary revascularization.1 Additional
arterial grafts,13 including BITA,2 have been proposed
to improve late survival after CABG, but definitive
conclusions are still lacking.3
Whether BITA is the better choice for patients in the long
term is still debated.3,5,7 Despite the improved long-term
outcome, the application of this technique in the elderly
population remains controversial because of their shorter
life expectancy and the excellent survival benefit obtained
with SITA. Whether the survival benefit from BITA is age
dependent and the potential age cutoff for the loss of
survival benefit remain to be determined.
To date, sporadic reports have previously addressed this
issue and reached conflicting conclusions. Mohammadi
and colleagues4 conducted a retrospective analysis on
1388 patients receiving BITA, and they concluded that
BITA provided survival advantage only for patients younger
than 60 years. In contrast, Kurlansky and coworkers6 found
that BITA improved survival across all patient age classes,
thus failing to show age as an effect modifier on survival
benefit from BITA. Kieser and associates7 investigated the
impact of BITA on late survival in a population of 1038
patients. They suggested age as an effect modifier on
survival benefit from BITA, but their analysis failed to
show a significant impact of BITA across all age classes
after adjustment for clinical variables. Toumpoulis and
colleagues8 analyzed the impact of BITA on survival in
patients with diabetes. They found no difference in 5-year
survival for patients younger than 60 or for those from 70
to 79 years old, but BITA did improve survival in patients
aged 60 to 69 years. It should be underlined that the age
cutoff in the previously mentioned studies was not derived
from the analysis of the effect of BITA across all patient
ages but was chosen arbitrarily, and this aspect makes the
study conclusions questionable.
This study investigated the effect of age on survival
benefit from BITA relative to SITA with a parametric
survival model adjusted for 19 pretreatment variables.
The interaction of age and BITA showed the age of 69 years
as a cutoff for the loss of survival benefit from BITA.gery c December 2014
FIGURE 1. A, Agreement between nonparametric (black) and flexible parametric (spline, red; Weibull, dashed blue; log logistic, dashed green) survival
curves in the overall study population. B, Agreement between nonparametric (black) and flexible spline parametric (red) survival curves in the bilateral
internal thoracic artery (BITA) and single internal thoracic artery (SITA) groups.
Benedetto et al Acquired Cardiovascular DiseaseIt can be speculated that the risk of death from noncardiac
causes increases with increasing age, thus neutralizing the
effect of BITA grafting on cardiac-related death. Moreover,
the loss of significant survival benefit from BITA grafting in
older patients might be related to their shorter life
expectancy, with patient age per se overshadowing the
potential advantage gained with BITA. On the other hand,
in younger patients (69 years), the beneficial effect ofTABLE 2. Univariate and multivariate parametric survival models
Univariate analysis
HR 95% CI
Age 1.08 1.06-1.09
Female 1.35 1.05-1.73
NYHA III/IV 2.12 1.71-2.63
MI 1.58 1.27-1.95
PCI 0.82 0.59-1.14
DM 1.66 1.33-2.07
Active smoking 0.84 0.58-1.22
COPD 1.55 1.12-2.13
CVA 2.16 1.52-3.07
PVD 1.76 1.27-2.45
AF 3.33 2.16-5.12
NVD 1.12 0.89-1.41
LMD 1.29 1.03-1.62
LVEF<50% 2.44 1.94-3.06
Urgent or emergency 1.89 1.52-2.36
Performed by resident 0.72 0.58-0.91
CPB 1.33 1.07-1.66
BMI 0.03 0.002-0.44
Creatinine 200 mmol/L 3.06 1.94-4.84
IABP 3.06 2-4.69
BITA 0.388 0.263-0.573
Age*BITA* — —
HR, Hazard ratio; CI, confidence interval; NYHA, New York Heart Association funct
DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascu
of vessels diseased; LMD, left main disease; LVEF, left ventricular ejection fraction; CPB
BITA, bilateral internal thoracic arteries. *Estimates obtained forcing the interaction term
The Journal of Thoracic and CarBITA grafting on cardiac-related death might account for
the observed improved overall survival. The survival benefit
from BITA was found to be present in both early and late
phases of the hazard function. It has been recognized that
the observed saphenous vein failure occurs in as many
as 25% of cases14 within 1 year after CABG. Early
vulnerability of SVG might explain the early survival
benefit observed among patients receiving BITA.15Multivariate analysis
P value HR 95% CI P value
<.0001 1.06 1.05-1.08 <.0001
.0183 1.14 0.87-1.49 .3452
<.0001 1.52 1.21-1.93 .0005
<.0001 1.2 0.95-1.51 .1230
.2400 — — —
<.0001 1.45 1.14-1.84 .0024
.3640 — — —
.0075 1.3 0.92-1.82 .1318
<.0001 1.45 1-2.11 .0507
.0008 1.23 0.86-1.74 .2523
<.0001 2.05 1.3-3.23 .0020
.3396 — — —
.0273 1.06 0.83-1.35 .6515
<.0001 1.64 1.27-2.11 .0001
<.0001 1.33 1.03-1.7 .0255
.0043 0.9 0.71-1.15 .3988
.0109 1.31 1.04-1.65 .0217
.0108 0.04 0.002-0.71 .0314
<.0001 1.8 1.11-2.93 .0175
<.0001 2.13 1.33-3.41 .0017
<.0001 0.02 0.0007-0.49 .0191
— 1.06 1.01-1.11 .0155
ional class; MI, myocardial infarction; PCI, percutaneous coronary intervention;
lar accident; PVD, peripheral vascular disease; AF, atrial fibrillation; NVD, number
, cardiopulmonary bypass; BMI, body mass index; IABP, intra-aortic balloon pump;
(age*BITA) in the final model.
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FIGURE 2. Hazard ratios (HR) and 95% confidence interval lower (L95%) and upper (U95%) bounds for bilateral internal thoracic artery grafting versus
single internal thoracic artery grafting according to patients age at surgery.
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SVG is further enhanced with longer follow-up.16 The
significant risk reduction for mortality among patients
aged 69 years or younger thus may result from the com-
bined early- and late phase benefits of using BITA grafting.FIGURE 3. Estimated survival (A and C) and hazard (B and D) functions for p
(C and D) receiving bilateral internal thoracic artery grafts (BITA, blue) or si
following covariates: New York Heart Association functional class, myocard
cerebrovascular accident, peripheral vascular disease, atrial fibrillation, left v
and intra-aortic balloon pump. adj, Adjusted; HR, hazard ratio; CI, confidence
2710 The Journal of Thoracic and Cardiovascular SurThere are limitations to this study. It is observational, and
we acknowledge that the revascularization strategies
occurred in a nonrandom fashion. We used a data set rich
in clinical detail, and although we had the ability to control
for important potential confounding variables, it is possibleatients aged 69 years or younger (A and B) and patients older than 69 years
ngle internal thoracic artery grafts (SITA, red). Estimates at means of the
ial infarction, diabetes mellitus, chronic obstructive pulmonary disease,
entricular ejection fraction, cardiopulmonary bypass, body mass index,
interval.
gery c December 2014
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(eg, patient fitness) are associated with both selection of
BITA grafting and outcome. In addition, BITA grafting
was performed by the surgeons most comfortable with the
procedure and not uniformly performed by all. We are
unable to attribute the improved survival unambiguously
to the effects of BITA use, specifically the presumed
enhanced patency rates, because neither the cause of death
nor graft patency data were available. All-cause death is
recommended to be considered in studies investigating
results of coronary intervention as a more reliable end point
than cause-specific mortality9; however, this is only one of
the outcomes relevant to the elderly population, and our
study has not analyzed other important effects, such as
improvement in quality of life, recurrent ischemia or
angina, or need for repeated revascularization. Finally, in
this analysis the number of subjects receiving BITA and
the number of deaths in the BITA group were relatively
small, and this in particular might have caused loss of
accuracy in the analysis.
In conclusion, our results provide scientific evidence for an
age cutoff for the loss of benefit from BITA. This robust
evidence supports the use of BITA in patients aged 69 years
and younger. Although a benefit extending into older age
cannot be formally excluded,17 the lack of evidence for
further survival benefit from BITA in older patients and the
potential risk for sternal wound infection related to BITA
use18 suggest the need to use clinical judgment in the selec-
tion of grafts for the older segment of the surgical population.
We thank all consultant cardiac surgeons who have operated at
Harefield Hospital during the study period for their contribution:
M. Amrani, T. Bahrami, F. de Robertis, G. Dreyfus, J. Gaer, A.
Khaghani, A. Moza, S. G. Raja, A. Simon, and S. Tadjkarimi.References
1. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW,
et al. Influence of the internal-mammary-artery graft on 10-year survival and
other cardiac events. N Engl J Med. 1986;314:1-6.
2. Lytle BW, Blackstone EH, Loop FD, Houghtaling PL, Arnold JH, Akhrass R,
et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc
Surg. 1999;117:855-72.The Journal of Thoracic and Car3. Taggart DP, Altman DG, Gray AM, Lees B, Nugara F, Yu LM, et al;
ART Investigators. Randomized trial to compare bilateral vs. single internal
mammary coronary artery bypass grafting: 1-year results of the Arterial
Revascularisation Trial (ART). Eur Heart J. 2010;31:2470-81.
4. Mohammadi S, Dagenais F, Doyle D, Mathieu P, Baillot R, Charbonneau E, et al.
Age cut-off for the loss of benefit from bilateral internal thoracic artery grafting.
Eur J Cardiothorac Surg. 2008;33:977-82.
5. Tatoulis J, Buxton BF, Fuller JA. The right internal thoracic artery: is it
underutilized? Curr Opin Cardiol. 2011;26:528-35.
6. Kurlansky PA, Traad EA, Dorman MJ, Galbut DL, Zucker M, Ebra G.
Thirty-year follow-up defines survival benefit for second internal mammary
artery in propensity-matched groups. Ann Thorac Surg. 2010;90:101-8.
7. Kieser TM, Lewin AM, Graham MM, Martin BJ, Galbraith PD, Rabi DM, et al;
APPROACH Investigators. Outcomes associated with bilateral internal thoracic
artery grafting: the importance of age. Ann Thorac Surg. 2011;92:1269-75;
discussion 1275-6.
8. Toumpoulis IK, Anagnostopoulos CE, Balaram S, Swistel DG, Ashton RC Jr,
DeRose JJ Jr. Does bilateral internal thoracic artery grafting increase
long-term survival of diabetic patients? Ann Thorac Surg. 2006;81:599-606;
discussion 606-7.
9. Holmes DR Jr, Kip KE, Kelsey SF, Detre KM, Rosen AD. Cause of death
analysis in the NHLBI PTCA Registry: results and considerations for evaluating
long-term survival after coronary interventions. J Am Coll Cardiol. 1997;30:
881-7.
10. Honaker J, King G, Blackwell M. Amelia II: a program for missing data. J Stat
Software. 2011;45:1-47.
11. Royston P, Parmar M. Flexible parametric proportional-hazards and
proportional-odds models for censored survival data, with application to
prognostic modelling and estimation of treatment effects. Stat Med. 2002;21:
2175-97.
12. Zucchini W. An Introduction to model selection. J Math Psychol. 2000;44:
41-61.
13. Benedetto U, Codispoti M. Age cutoff for the loss of survival benefit from use of
radial artery in coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2013;
146:1078-84; discussion 1084-5.
14. Magee MJ, Alexander JH, Hafley G, Ferguson TB Jr, Gibson CM,
Harrington RA, et al; PREVENT IV Investigators. Coronary artery bypass
graft failure after on-pump and off-pump coronary artery bypass: findings
from PREVENT IV. Ann Thorac Surg. 2008;85:494-9; discussion 499-
500.
15. Halabi AR, Alexander JH, Shaw LK, Lorenz TJ, Liao L, Kong DF, et al. Relation
of early saphenous vein graft failure to outcomes following coronary artery
bypass surgery. Am J Cardiol. 2005;96:1254-9.
16. Cao C, Ang SC, Wolak K, Peeceeyen S, Bannon P, Yan TD. A meta-analysis of
randomized controlled trials on mid-term angiographic outcomes for radial
artery versus saphenous vein in coronary artery bypass graft surgery. Ann
Cardiothorac Surg. 2013;2:401-7.
17. Raja SG. Myocardial revascularization for the elderly: current options, role of
off-pump coronary artery bypass grafting and outcomes. Curr Cardiol Rev.
2012;8:26-36.
18. Nakano J, Okabayashi H, Hanyu M, Soga Y, Nomoto T, Arai Y, et al. Risk
factors for wound infection after off-pump coronary artery bypass grafting:
should bilateral internal thoracic arteries be harvested in patients with diabetes?
J Thorac Cardiovasc Surg. 2008;135:540-5.diovascular Surgery c Volume 148, Number 6 2711
